Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Neoplasms, Nerve Tissue 2Glioma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Neoplasm Metastasis 1Liver Neoplasms 1Fibrosis 1Colon Cancer Liver Metastasis 1Carcinoma, Pancreatic Ductal 1Ascites 1Abdominal Neoplasms 1Abdominal Injuries 1

Interventions

Fluorouracil 498Bevacizumab 476Oxaliplatin 450Leucovorin 442Irinotecan 408Cetuximab 318Capecitabine 317pembrolizumab 142Folfox protocol 128Panitumumab 117regorafenib 105Colonoscopy 88Nivolumab 82IFL protocol 81Drug Therapy 77trifluridine tipiracil drug combination 73Radiotherapy 66HMPL-013 65Blood Specimen Collection 52Gemcitabine 49Specimen Handling 47Standard of Care 45Neoadjuvant Therapy 45Magnetic Resonance Spectroscopy 44Biopsy 44Chemotherapy, Adjuvant 41Trifluridine 40atezolizumab 39Cyclophosphamide 39Surveys and Questionnaires 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colorectal Neoplasms × contrast agent BR1 × Clear all
NCT03477019 2023-01-19

Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer

St. Olavs Hospital

Phase 1/2 Completed
17 enrolled
BreastGastrointestinal

Breast Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT02457390 2016-01-26

CE-LUS

Odense University Hospital

Phase NA Completed
50 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡